| 25 May 2026 |
SR9009 |
10.0 |
10mg |
10.0mg |
+0.2% |
96.29% |
Lab A |
| 24 May 2026 |
N-Acetyl Epitalon Amidate |
7.7 |
15mg |
16.7mg |
+11.4% |
98.14% |
Lab C |
| 24 May 2026 |
BPC157 5mg + TB500 5mg Blend |
9.6 |
20mg |
19.0mg |
-5.1% |
95.20% |
Lab C |
| 24 May 2026 |
Selank 10mg + Semax 10mg Blend |
9.4 |
15mg |
13.8mg |
-7.7% |
99.75% |
Lab G |
| 24 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
8.6 |
30mg |
28.5mg |
-5.2% |
99.77% |
Lab B |
| 24 May 2026 |
Cerebrolysin |
10.0 |
5mg |
4.7mg |
-6.6% |
96.98% |
Lab F |
| 24 May 2026 |
CJC-1295 With DAC |
10.0 |
2mg |
2.1mg |
+2.5% |
98.17% |
Lab G |
| 24 May 2026 |
SS-31 (Elamipretide) Raw |
8.8 |
10g |
11.0g |
+10.0% |
95.39% |
Lab G |
| 24 May 2026 |
Thymalin |
8.0 |
2mg |
2.0mg |
-2.4% |
96.04% |
Lab F |
| 23 May 2026 |
RIPEX 225 (TRA/Mast P/Test P) |
8.1 |
100mg/ml |
117.1mg/ml |
+17.1% |
99.68% |
Lab E |
| 23 May 2026 |
4-Anilinopiperidine CAS 99918-43-1 |
8.5 |
1g |
1.2g |
+23.7% |
97.13% |
Lab E |
| 23 May 2026 |
SLU-PP-332 |
7.5 |
100mg |
98.6mg |
-1.4% |
98.32% |
Lab A |
| 22 May 2026 |
Retatrutide |
7.2 |
30mg |
33.8mg |
+12.7% |
99.61% |
Lab E |
| 22 May 2026 |
Retatrutide |
9.1 |
30mg |
32.3mg |
+7.7% |
99.90% |
Lab E |
| 20 May 2026 |
VIP |
5.6 |
2mg |
2.4mg |
+22.3% |
98.32% |
Lab B |
| 19 May 2026 |
Selank |
10.0 |
10mg |
9.3mg |
-6.6% |
98.84% |
Lab E |
| 29 Jan 2026 |
Prostamax |
9.5 |
2mg |
2.4mg |
+20.6% |
97.12% |
Lab C |
| 29 Jan 2026 |
Turinabol |
9.7 |
20mg |
19.4mg |
-3.0% |
97.32% |
Lab G |
| 26 Jan 2026 |
Dihexa |
7.2 |
20mg |
23.6mg |
+17.9% |
96.47% |
Lab E |
| 26 Jan 2026 |
LGD-4033 (Ligandrol) |
7.6 |
50mg |
45.4mg |
-9.3% |
99.17% |
Lab F |
| 9 Jan 2026 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
8.1 |
10mg |
11.1mg |
+11.5% |
95.32% |
Lab E |
| 9 Jan 2026 |
T3 (Liothyronine) |
7.5 |
50mg |
50.7mg |
+1.4% |
98.73% |
Lab B |
| 7 Jan 2026 |
KPV Oral |
8.9 |
100mg |
110.6mg |
+10.6% |
97.82% |
Lab E |
| 7 Jan 2026 |
TriTren 225 |
10.0 |
200mg/ml |
249.5mg/ml |
+24.8% |
95.09% |
Lab B |
| 6 Jan 2026 |
Botulinum toxin |
5.6 |
5mg |
6.0mg |
+20.3% |
99.20% |
Lab D |
| 29 Dec 2025 |
MENT (Trestolone Acetate) |
9.1 |
300mg/ml |
310.4mg/ml |
+3.5% |
97.24% |
Lab A |
| 12 Dec 2025 |
Andarine S4 |
6.7 |
10mg |
8.9mg |
-11.5% |
97.26% |
Lab E |
| 12 Dec 2025 |
KissPeptin-10 |
6.7 |
5mg |
5.0mg |
-0.9% |
99.41% |
Lab B |
| 5 Dec 2025 |
IGF-1 LR3 |
6.0 |
2mg |
1.9mg |
-6.0% |
99.68% |
Lab F |
| 5 Dec 2025 |
Super Shred |
8.3 |
250mg/ml |
293.4mg/ml |
+17.4% |
96.45% |
Lab A |
| 23 Nov 2025 |
Vilon |
9.5 |
5mg |
4.6mg |
-7.6% |
99.03% |
Lab F |
| 17 Nov 2025 |
Arimidex (Anastrozole) |
9.6 |
100mg |
119.4mg |
+19.4% |
98.15% |
Lab G |
| 17 Nov 2025 |
Romosozumab |
7.5 |
2mg |
2.3mg |
+12.5% |
96.84% |
Lab F |
| 4 Nov 2025 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
10.0 |
5mg |
4.5mg |
-10.1% |
97.63% |
Lab G |
| 9 Oct 2025 |
Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) |
8.0 |
100mg/ml |
90.4mg/ml |
-9.6% |
98.14% |
Lab C |
| 3 Oct 2025 |
5-amino-1MQ |
10.0 |
30mg |
34.0mg |
+13.3% |
99.01% |
Lab C |
| 3 Oct 2025 |
PEG MGF |
10.0 |
50mg |
45.1mg |
-9.9% |
98.85% |
Lab E |